Leiden Bio Science Park is one of the oldest of its kind in the world. However, there is nothing old-fashioned about its approach to science or attracting investment.

The Wallonia region of Belgium has built itself up into a life sciences hub, leveraging on its range of academic and medical resources and central location.

Countries all over the world are fighting for a share of the potentially lucrative biotech market, with emerging markets going all out to challenge traditional strongholds. Karen Thuermer assesses which locations are out in front or showing the strongest potential.

The biotechnology sector has seen increasing levels of investment and job creation in recent years, and has become an important sector for those charged with investment attraction. Cathy Mullan reports on the locations getting it right. 

Kaunas has established a reputation as a medical technology and R&D hub for the Baltic region. Its next step, as Natasha Turak discovers, is to ensure that its technological prowess is acknowledged on a global scale.

Lexington Medical’s expansion highlights its optimism about the wealth of expertise in the medical device industry in Massachusetts, as the locally incubated company opens a headquarters in the state. Natasha Turak reports.

Cologne's biotech centre BioCampus is branching out from its original purpose. Director André van Hall tells Natasha Turak why an interdisciplinary approach is the way forward.

Ute Berg, general manager of BioCampus Cologne and deputy mayor for economic development and real estate, explains to fDi how innovation and technology are vital for the future prosperity of the city.

Soaring costs at the US's major biotech hubs such as Boston and California are moving the spotlight to second-tier locations. But how can the likes of Philadelphia, Minneapolis and Maryland stand out from the crowd at attract investment in this lucrative sector? Michal Kaczmarski finds out.